Keren Shoshani-Haye is a Scientific Analyst focused on life sciences intellectual property and patent strategy for biotechnology innovations. She supports patent preparation, patentability analysis, and prior art evaluation.

Dr. Shoshani-Haye has research experience across academia and industry. Her scientific background spans molecular biology, functional genomics, epigenetics, advanced microscopy, and computational data analytics. She has authored multiple peer-reviewed publications and applied her professional background to analyze complex scientific data, evaluate patentability, and support strategic patent drafting and prosecution.

Keren’s graduate and post-graduate research focused on developmental neurobiology and the molecular basis for affective disorders, where she developed and applied advanced sequencing techniques, in vivo models, and bioinformatic analysis. She has also developed experience in innovation evaluation and technology strategy through the National Forum for Bio-Innovators, assessing scientific novelty, competitive positioning, and commercial potential of biologics-based technologies.

Dr. Shoshani-Haye earned her Ph.D. and M.Sc. in molecular neuroscience from the Weizmann Institute of Science and her B.Sc. in cognitive sciences and life sciences from the Hebrew University of Jerusalem, graduating with distinction.